Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-16-028936
Filing Date
2016-08-23
Accepted
2016-08-23 15:10:16
Documents
1
Period of Report
2016-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 4/A - edgar.html 4/A  
1 FORM 4/A - edgar.xml 4/A 5834
  Complete submission text file 0001179110-16-028936.txt   7299
Mailing Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034
Business Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034 610-527-6790
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INCYTE CORPORATION 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address
FRIEDMAN PAUL A (Reporting) CIK: 0001236927 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-33277 | Film No.: 161847120